血糖控制与2型糖尿病合并慢性肾病患者急性肾损伤风险:美国与瑞典平行人群队列研究
该研究在美国Geisinger健康系统和瑞典SCREAM项目中,纳入2型糖尿病合并CKD G3-G5期成人,评估基线及时间更新HbA1c与急性肾损伤(AKI)的关系。两个队列中较高的HbA1c均与AKI风险增加相关,提示改善血糖控制可能降低AKI风险。
要点
- 在2型糖尿病合并CKD G3-G5期成人中,较高HbA1c与急性肾损伤风险增加独立相关。
- 与美国队列相比,瑞典队列中HbA1c>9%与AKI风险的关联方向与幅度一致。
- 改善血糖控制可能有助于降低该类患者急性肾损伤的风险。
核心结论
- 在2型糖尿病合并CKD的成人中,较高的HbA1c与急性肾损伤风险增加相关。
- 研究结果提示改善血糖控制可能降低急性肾损伤风险。
研究设计与样本
- 研究为两个观察性队列:美国Geisinger健康系统队列和瑞典SCREAM项目队列。
- 纳入对象为2型糖尿病合并确诊CKD G3-G5期、接受常规医疗的成人。
- 瑞典队列12157例(女性50%),中位年龄77岁,中位eGFR 51 mL/min/1.73 m2。
- 评估基线及时间更新HbA1c与 incident AKI(定义为48小时内肌酐升高≥0.3 mg/dL或7天内肌酐升至1.5倍)的关联。
主要发现
- 美国队列随访3.1年期间记录7060例AKI事件,瑞典队列随访2.3年期间记录2619例AKI事件。
- 与基线HbA1c 6-6.9%(42-52 mmol/mol)相比,HbA1c>9%(75 mmol/mol)者AKI风险在Geisinger队列的HR为1.29(95%CI 1.18-1.41)。
- 同一比较在瑞典队列的HR为1.33(95%CI 1.13-1.57)。
- 基线HbA1c与AKI的校正关联在两个队列中相似。
- 分层分析、以死亡为竞争风险及使用时间更新HbA1c时结果一致。
关键数值与推荐
- AKI定义:48小时内肌酐升高≥0.3 mg/dL或7天内肌酐升至1.5倍。
- 参考组基线HbA1c为6-6.9%(42-52 mmol/mol)。
- HbA1c>9%(75 mmol/mol)与AKI关联的HR:Geisinger 1.29(95%CI 1.18-1.41),瑞典1.33(95%CI 1.13-1.57)。
临床怎么用
- 对2型糖尿病合并CKD G3-G5期患者,应关注血糖控制水平与急性肾损伤风险。
- 较高的HbA1c(如>9%)提示AKI风险增加,临床可据此加强监测与血糖管理。
局限性
- 研究为观察性设计,不能确立因果关系。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with diabetes and chronic kidney disease (CKD) have increased susceptibility to acute kidney injury (AKI), but mechanisms are unclear. We investigated the association of glycemic control with risk of AKI. RESEARCH DESIGN AND METHODS: In two observational cohorts of U.S. (Geisinger Health System, Danville, PA) and Swedish (Stockholm CREAtinine Measurements [SCREAM] project, Stockholm, Sweden) adults with type 2 diabetes and confirmed CKD stages G3-G5 undergoing routine care, we evaluated associations between baseline and time-varying hemoglobin A1c (HbA1c) with the incident AKI (defined as increase in creatinine ≥0.3 mg/dL over 48 h or 1.5 times creatinine over 7 days). RESULTS: In the U.S. cohort, there were 22,877 patients (55% women) with a median age of 72 years and estimated glomerular filtration rate (eGFR) 52 mL/min/1.73 m2. In the Swedish cohort, there were 12,157 patients (50% women) with a median age of 77 years and eGFR 51 mL/min/1.73 m2. During 3.1 and 2.3 years of follow-up, 7,060 and 2,619 AKI events were recorded in the U.S. and Swedish cohorts, respectively. The adjusted association between baseline HbA1c and AKI was similar in both cohorts. Compared with baseline HbA1c 6-6.9% (42-52 mmol/mol), the hazard ratio for AKI in patients with HbA1c >9% (75 mmol/mol) was 1.29 (95% CI 1.18-1.41) in Geisinger and 1.33 (95% CI 1.13-1.57) in the Swedish cohort. Results were consistent in stratified analysis, when using death as competing risk, and when using time-varying HbA1c. CONCLUSIONS: Higher HbA1c was associated with AKI in adults with type 2 diabetes and CKD, suggesting that improving glycemic control may reduce the risk of AKI.
引用
- Xu Y, Surapaneni A, Alkas J, et al. Glycemic Control and the Risk of Acute Kidney Injury in Patients With Type 2 Diabetes and Chronic Kidney Disease: Parallel Population-Based Cohort Studies in U.S. and Swedish Routine Care. Diabetes Care. 2020. PMID: 33023987. doi:10.2337/dc20-1588
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。